FindTrial
Sign In

A real world study on the efficacy and safety of COVID-19 vaccine in breast cancer patients

A real world study on the efficacy and safety of COVID-19 vaccine in breast cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055509
Enrollment
Unknown
Registered
2022-01-11
Start date
2022-01-15
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Sponsors

the Fifth Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with complete data; 2. Pathological diagnosed as invasive breast cancer; 3. Voluntary to be followed up and provide effective vaccination data; 4. No distant metastatic lesion; 5. Estimated survival time of more than 3 months.

Exclusion criteria

Exclusion criteria: 1. Ductal carcinoma in situ; 2. Combined with other malignant tumors; 3. Not suitable to participate in this study per other researchers.

Design outcomes

Primary

MeasureTime frame
efficacy;safety;—

Countries

China

Contacts

Public ContactJiang Zefei

the Fifth Medical Center of PLA General Hospital

jiangzefei@csco.org.cn+86 13901372170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026